Nifty MidSmall Healthcare

NSE: NFTYMIDSMH

41402.00 208.75 (0.51%)

32.36% Gain from 52W Low

NSE 21 May, 2025 3:31 PM (IST)

Nifty MidSmall Healthcare PB	6.1
Nifty MidSmall Healthcare PE	45.2
Nifty MidSmall Healthcare DIV	0.4
Nifty MidSmall Healthcare EPS	916.6

Nifty MidSmall Healthcare Corporate Filings & Announcements

Latest corporate announcements and filings from Nifty MidSmall Healthcare on BSE

Load latest

J B Chemicals & Pharmaceuticals Ltd.

15 May 2025

1670.50

-1.86%

Earnings Call

JB Chemicals & Pharmaceuticals Ltd - 506943 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet …

BSE India

Audio recording of Investors/analysts call with Management

Neuland Laboratories Ltd.

15 May 2025

11194.00

0.39%

Company Update

Neuland Laboratories Ltd - 524558 - Appointment Of Secretarial Auditors Of The Company

BSE India

Appointment of Secretarial Auditors of the Company

Global Health Ltd.

15 May 2025

1183.10

-0.59%

Company Update

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Announcement regarding appointment of Dr. Pankaj Dhamija as one of the Senior Management Personnel.

Neuland Laboratories Ltd.

15 May 2025

11194.00

0.39%

Company Update

Neuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Re-appointment of Mr. Davuluri Saharsh Rao (DIN: 02753145), as Whole Time Director, designated as Vice Chairman and Managing Director

J B Chemicals & Pharmaceuticals Ltd.

15 May 2025

1670.50

-1.86%

Company Update

JB Chemicals & Pharmaceuticals Ltd - 506943 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper advertisement pertaining to financial results for quarter and year ended on March 31, 2025

Global Health Ltd.

15 May 2025

1183.10

-0.59%

Corp. Note

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Dividend Updates

BSE India

Intimation for outcome of Board meeting for recommending final dividend.

Neuland Laboratories Ltd.

15 May 2025

11194.00

0.39%

Corp. Note

Neuland Laboratories Ltd - 524558 - Corporate Action-Board approves Dividend

BSE India

Recommendation of final dividend for the financial year 2024-25

Neuland Laboratories Ltd.

15 May 2025

11194.00

0.39%

Investor Presentation

Neuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation on the Financial Results of the Company for the quarter and year ended March 31, 2025

Global Health Ltd.

15 May 2025

1183.10

-0.59%

Result

Global Health Ltd - 543654 - Results For The Quarter And Financial Year Ended March 31, …

BSE India

Results for the Quarter and Financial year ended March 31, 2025

	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	954.18	959.46	836.05	-0.6%	14.1%
Operating Profit Qtr	224.69	237.76	179.35	-5.5%	25.3%
Net Profit Qtr	101.40	142.91	127.38	-29.0%	-20.4%
Earning Per Share Adjusted latest Qtr	3.77	5.32	4.74	-29.1%	-20.5%

* Consolidated data

Detailed Results

Neuland Laboratories Ltd.

15 May 2025

11194.00

0.39%

Company Update

Neuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release on the Financial Results of the Company for the quarter and year ended March 31, 2025